Clinical Oncology Podcast

A discussion with Prof Karen Canfell on cervical cancer elimination. In our second episode, we discuss the Global Strategy for cervical cancer elimination with Prof Karen Canfell, Director of the Daffodil Centre, University of Sydney and Cancer Council, New South Wales. .

A discussion with Dr Umesh Mahantshetty and Dr Sophie Otter We discuss the highlights of our latest Special Issue, with a focus on cervical cancer care in low and middle income countries.

A discussion with Dr Sophie Otter and Dr Saif Ahmad, current members of the Clinical Oncology Editorial Board, hosted by Dr Fin Slevin, Trainee Editor.This discussion with current Editorial Board members explores the role of the Editorial Board and the advantages and opportunities associated with being an editor.

Chaired by Prof Robert Huddart (Guest Editor of our latest Special Issue - Bladder Radiotherapy) and co-hosted by Drs Finbar Slevin and Saif Ahmad we discuss key aspects of bladder cancer treatment with experts , Prof Jim Catto, Prof Valerie Fonteyne, Dr Lydia Makaroff and Dr Mohini Varughese.

We discuss the new Instant Oncology editorial series with our Assistant Editor Dr Ben O'Leary and Instant Oncology creator Dr Lei Wang.

We discuss COVID-RT: a national UK initiative that aims to study the impact of the COVID-19 pandemic on UK radiotherapy services and patient outcomes

Finbar Slevin, clinical oncology trainee at Leeds Cancer Centre, speaks to Anna Olsson-Brown and Chris Jones about how NOTCH was established, current and future projects and its engagement with trainee oncologists in the UK

Anthi Zeniou and Finbar Slevin, speciality trainees in Clinical Oncology, interview Dr Katy Clarke following her award of the RCR ORF Trainer Award for 2019. They explore how she has developed teaching and training in Leeds, especially with regards to FRCR examinations, addressed challenges such as staffing and service pressures and supported her trainees throughout their training.

Anthi Zeniou and Finbar Slevin, speciality trainees in Clinical Oncology, interview Dr Katy Clarke following her award of the RCR ORF Trainer Award for 2019. They explore how she has developed teaching and training in Leeds, especially with regards to FRCR examinations, addressed challenges such as staffing and service pressures and supported her trainees throughout their training.

We discuss the exciting new technology of MRI radiotherapy and how it may potentially transform clinical radiotherapy.

As the first NHS patient to be treated by proton beam therapy draws nearer, we review the special issue with its Guest Editor and also discuss how the UK radiotherapy research community plans to make the most out of this new technology.

We discuss the radiation physics and associated biology underlying the science of proton beam and particle therapy

We discuss the experience of proton beam therapy within the US and the associated benefits and challenges

We discuss the aims of ARTNET (Advanced Radiotherapy Technologies Network) - which was recently awarded a CRUK Network Accelerator Award

We speak with Prof David Dodwell, based at Leeds Cancer Centre, about his recent editorial in Clinical Oncology on how to improve breast cancer care

We speak with Prof Nick Reed, based at the Beatson Oncology Centre in Glasgow. He is a guest editor on the latest Clinical Oncology Special Issue on thyroid cancer

In conjunction with the latest Clinical Oncology Special Issue we hear in part 2 of the podcast from Dr Jesper Grau Eriksen, Prof Yolande Lievens, Dr Mei-Ling Yap, Dr Danielle Rodin and Dr Mora Mel about how we can solve the massive inequality in radiotherapy provision across the world.

In conjunction with the latest Clinical Oncology Special Issue we hear from Prof Yolande Lievens, Dr Mei-Ling Yap, Dr Danielle Rodin and Dr Mel Mora

We speak with Prof Hardev Pandha, Professor of Medical Oncology at the University of Surrey, about his excellent Science in Focus article from earlier this year - Oncolytic Viruses: New Multifunctional Immunotherapeutics

We speak with Prof Anthony Chalmers, Chair of Clinical Oncology at the University of Glasgow, about the exciting area of combining radiotherapy with drugs targeting the DNA damage response